CD16 (beta unit, short)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb13/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb13/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb12/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb12/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb11/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb11/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb10/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb10/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb0f/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb0f/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb0e/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb0e/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb0d/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb0d/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb0c/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb0c/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb0b/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb0b/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb0a/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb0a/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb09/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb09/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb08/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb08/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb07/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb07/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb06/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb06/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb05/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb05/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb04/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb04/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb03/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb03/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb02/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb02/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb01/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb01/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fb00/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fb00/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faff/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faff/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fafe/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fafe/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fafd/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fafd/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fafc/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fafc/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fafb/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fafb/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6fafa/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6fafa/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faf9/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faf9/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faf8/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faf8/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faf7/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faf7/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faf6/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faf6/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faf5/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faf5/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faf4/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faf4/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faf3/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faf3/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faf2/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faf2/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faf1/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faf1/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faf0/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faf0/cd16-beta-unit-short.png"},{"image":"https://icons.biorender.com/w75xh75/63331fabd8c4400021f6faef/cd16-beta-unit-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/63331fabd8c4400021f6faef/cd16-beta-unit-short.png"}]
Keywords
CD16,Fc receptor,Fc region,FcγRIII,FCGR3A,beta unit,beta domain,beta,ITAM,ITAM domains,short,CD16